Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06022029
Title A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. (ON-5001)
Acronym ON-5001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoNano Medicine, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
BRCR Global RECRUITING Tamarac Florida 33321 United States Details
Ohio State University RECRUITING Columbus Ohio 43210 United States Details
Allegheny Health Network RECRUITING Pittsburgh Pennsylvania 15224 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
University of Texas Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field